Italian medicines agency AIFA said
Wednesday that its technical-scientific committee had approving
using the Spikevax (Moderna) vaccine with minors aged from 12
to 17.
The committee said the data available showed that the Moderna
vaccine was effective and safe for this age group.
The approval came after the European Medicines Agency gave the
green light.
It is the second COVID vaccine to be approved for
12-to-17-year-olds in Italy after the Pfizer one.
ALL RIGHTS RESERVED © Copyright ANSA
